J Korean Med Assoc.
2022 Mar;65(3):157-166. 10.5124/jkma.2022.65.3.157.
Treatment of acute respiratory failure: extracorporeal membrane oxygenation
- Affiliations
-
- 1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2527356
- DOI: http://doi.org/10.5124/jkma.2022.65.3.157
Abstract
- Background
Extracorporeal membrane oxygenation (ECMO) support for tissue oxygenation can improve the survival of patients with life-threatening respiratory distress syndrome or cardiac failure.
Current Concepts
Recently, the use of ECMO in acute respiratory distress syndrome has first been reported by a multicenter randomized controlled trial, known as the conventional ventilation or ECMO for severe adult respiratory failure trial. The ECMO application is dramatically increasing with the increasing number of patients experiencing acute respiratory failure due to coronavirus disease 2019 pneumonia. In this review, we explain the indications of the ECMO application and ECMO-associated complications.
Discussion and Conclusion
The ECMO application in lung diseases, such as coronavirus disease 2019 and acute respiratory distress syndrome, has significant outcomes in securing the treatment periods and reducing mortality. Therefore, accumulating knowledge and experience in the ECMO application can produce positive outcomes.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Successful Treatment in Fatal Adenovirus Pneumonia with the Use of Extracorporeal Membrane Oxygenation
- Recovery from Acute Respiratory Distress Syndrome with Long-Run Extracorporeal Membrane Oxygenation
- The Treatment of Adult Respiratory Distress Syndrome (ARDS) Using Extracorporeal Membrane Oxygenation (ECMO)
- Successful Retrieval of a Fractured Guidewire during Extracorporeal Membrane Oxygenator Insertion
- Extracorporeal Membrane Oxygenation Treatment of Traumatic Lung Injury: 2 Cases
